Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth

A vaccine will likely be one of the key tools for ending the HIV-1/AIDS epidemic by preventing HIV-1 spread within uninfected populations and achieving a cure for people living with HIV-1. The currently prevailing view of the vaccine field is to introduce protective antibodies, nevertheless, a vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyo, Nathifa, Wee, Edmund G., Korber, Bette, Bahl, Kapil, Falcone, Samantha, Himansu, Sunny, Wong, Adrianne L., Dey, Antu K., Feinberg, Mark, Hanke, Tomáš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563622/
https://www.ncbi.nlm.nih.gov/pubmed/32640600
http://dx.doi.org/10.3390/vaccines8030360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563622/
https://www.ncbi.nlm.nih.gov/pubmed/32640600
http://dx.doi.org/10.3390/vaccines8030360

Ejemplares similares